Uncategorized

Servatus Biopharmaceuticals Joins Microbiome Therapeutics Innovation Group

By webadmin|2021-03-29T08:30:18-04:00March 29th, 2021|Uncategorized|0 Comments

Microba Life Sciences joins Microbiome Therapeutics Group

WASHINGTON, Feb. 22, 2021 -- The Microbiome Therapeutics Innovation Group (MTIG) [...]

By webadmin|2021-03-04T14:39:49-05:00March 4th, 2021|Uncategorized|0 Comments

Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660

By webadmin|2020-02-20T08:26:27-05:00February 4th, 2020|Uncategorized|0 Comments

Vedanta Biosciences Announces Initiation of First-in-Patient Study of Immuno-Oncology Candidate VE800 In Combination with Bristol-Myers Squibb’s Opdivo® (Nivolumab)

By webadmin|2020-01-10T00:17:58-05:00December 5th, 2019|Uncategorized|0 Comments

Interview with Jim Weston and Stephen Conafay of MTIG

By webadmin|2019-10-01T14:34:05-04:00October 1st, 2019|Uncategorized|0 Comments

Microbiome Therapeutics Innovation Group Highlights Member Company Activity at IDWeek 2019

By webadmin|2019-10-01T13:08:59-04:00October 1st, 2019|Uncategorized|0 Comments

LUCA Biologics Launches to Develop Live Biotherapeutics for Women’s Health Starting with Urinary Tract Infection (UTI)

By webadmin|2019-08-07T10:46:10-04:00August 7th, 2019|Uncategorized|0 Comments

Seed Health Joins Microbiome Therapeutics Innovation Group

By webadmin|2019-07-16T10:27:29-04:00July 16th, 2019|Uncategorized|0 Comments

Rebiotix Leaders to Discuss Microbiome Product Development Challenges and Regulation at Microbiome Movement – Drug Development Summit 2019

By webadmin|2020-02-20T08:10:06-05:00July 1st, 2019|Uncategorized|0 Comments

Microbiome Therapeutics Innovation Group Statement on FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms

By webadmin|2019-06-17T10:45:10-04:00June 17th, 2019|Uncategorized|0 Comments